By Andrew Silver SHANGHAI, June 29 (Reuters) - GLP-1 drugs from Pfizer and Innovent Biologics have passed a preliminary ...
SHANGHAI, June 29 (Reuters) - Pfizer's ecnoglutide and Innovent Biologics' mazdutide have passed a preliminary review to be ...
Pfizer's GLP-1 drug showed 12% weight loss over six months with just one monthly injection. Experts say it could be years before it receives regulatory approval ...
Pfizer (PFE) announced early Monday that it is halting a late-stage trial of its GLP-1 pill candidate, danuglipron, dashing hopes of the company entering the obesity space in the near term. A trial ...
Pfizer’s top cancer drugs are small molecules, but dealmaking has expanded the pharmaceutical giant’s portfolio and pipeline with biologic medicines. Its latest deal puts it in a camp of companies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results